Stock YMAB Y-MABS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Y-mAbs Therapeutics, Inc.

Equities

YMAB

US9842411095

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
12.1 USD +0.75% Intraday chart for Y-mAbs Therapeutics, Inc. -0.98% +77.42%
Jun. 01 Y-mAbs Therapeutics, Inc. Announces New Interim Analysis of Phase 2 Data for Naxitamab At 2024 Asco Annual Meeting CI
May. 08 Transcript : Y-mAbs Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. YMAB Stock
  4. News Y-mAbs Therapeutics, Inc.
  5. Official Publications